HKD4.70
1.29% day before yesterday
Hong Kong, Jul 18, 10:08 am CET
ISIN
BMG0171K1018
Symbol
0241
Index
Sector
Industry

Alibaba Health Information Technology Target price 2025 - Analyst rating & recommendation

Alibaba Health Information Technology Classifications & Recommendation:

Buy
59%
Hold
32%
Sell
9%

Alibaba Health Information Technology Price Target

Target Price HKD4.90
Price HKD4.70
Potential
Number of Estimates 19
19 Analysts have issued a price target Alibaba Health Information Technology 2026 . The average Alibaba Health Information Technology target price is HKD4.90. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 22 analysts: 13 Analysts recommend Alibaba Health Information Technology to buy, 7 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Alibaba Health Information Technology stock has an average upside potential 2026 of . Most analysts recommend the Alibaba Health Information Technology stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '25 2026
Estimates
Revenue Billion HKD 33.45 37.08
13.22% 10.84%
Net Margin 4.68% 7.16%
43.21% 52.95%

18 Analysts have issued a sales forecast Alibaba Health Information Technology 2026 . The average Alibaba Health Information Technology sales estimate is

HKD37.1b
Unlock
. This is
10.84% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD41.5b 24.11%
Unlock
, the lowest is
HKD33.4b 0.14%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 HKD33.5b 13.22%
2026
HKD37.1b 10.84%
Unlock
2027
HKD41.1b 10.94%
Unlock
2028
HKD43.7b 6.31%
Unlock
2029
HKD49.3b 12.84%
Unlock
2030
HKD57.1b 15.71%
Unlock
2031
HKD62.4b 9.33%
Unlock
2032
HKD68.1b 9.12%
Unlock

18 Alibaba Health Information Technology Analysts have issued a net profit forecast 2026. The average Alibaba Health Information Technology net profit estimate is

HKD2.7b
Unlock
. This is
69.41% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD3.3b 107.62%
Unlock
, the lowest is
HKD2.1b 32.12%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 HKD1.6b 62.13%
2026
HKD2.7b 69.41%
Unlock
2027
HKD3.2b 21.08%
Unlock
2028
HKD3.5b 8.81%
Unlock
2029
HKD4.5b 28.37%
Unlock
2030
HKD4.8b 6.46%
Unlock
2031
HKD5.5b 14.81%
Unlock
2032
HKD6.2b 12.90%
Unlock

Net Margin

2025 4.68% 43.21%
2026
7.16% 52.95%
Unlock
2027
7.81% 9.08%
Unlock
2028
7.99% 2.30%
Unlock
2029
9.09% 13.77%
Unlock
2030
8.37% 7.92%
Unlock
2031
8.78% 4.90%
Unlock
2032
9.09% 3.53%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '25 2026
Estimates
Earnings Per Share HKD 0.10 0.16
42.86% 60.00%
P/E 28.51
EV/Sales 1.78

18 Analysts have issued a Alibaba Health Information Technology forecast for earnings per share. The average Alibaba Health Information Technology EPS is

HKD0.16
Unlock
. This is
60.00% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
HKD0.20 100.00%
Unlock
, the lowest is
HKD0.13 30.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 HKD0.10 42.86%
2026
HKD0.16 60.00%
Unlock
2027
HKD0.20 25.00%
Unlock
2028
HKD0.22 10.00%
Unlock
2029
HKD0.28 27.27%
Unlock
2030
HKD0.30 7.14%
Unlock
2031
HKD0.34 13.33%
Unlock
2032
HKD0.38 11.76%
Unlock

P/E ratio

Current 47.00 0.60%
2026
28.51 39.34%
Unlock
2027
23.55 17.40%
Unlock
2028
21.64 8.11%
Unlock
2029
16.86 22.09%
Unlock
2030
15.84 6.05%
Unlock
2031
13.79 12.94%
Unlock
2032
12.22 11.39%
Unlock

Based on analysts' sales estimates for 2026, the Alibaba Health Information Technology stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.97 34.93%
2026
1.78 9.68%
Unlock
2027
1.60 9.86%
Unlock
2028
1.51 5.93%
Unlock
2029
1.34 11.38%
Unlock
2030
1.16 13.58%
Unlock
2031
1.06 8.53%
Unlock
2032
0.97 8.36%
Unlock

P/S ratio

Current 2.24 23.70%
2026
2.02 9.78%
Unlock
2027
1.82 9.86%
Unlock
2028
1.71 5.93%
Unlock
2029
1.52 11.38%
Unlock
2030
1.31 13.58%
Unlock
2031
1.20 8.54%
Unlock
2032
1.10 8.36%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today